Answers are grounded in this paper and cite their sources.
Identifying patients at excess risk for severe COVID-19 is critical for devising treatment strategies (particularly those involving immune modulation)
No takes yet. Share an insight, caveat, or question.
Neil M. Ampel (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: